PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine II, Medical Center - University of Freiburg and Faculty of Medicine, University Hospital Freiburg, Freiburg, Germany.\', \'Institute of Virology, University of Freiburg and Faculty of Medicine, University Hospital Freiburg, Freiburg, Germany.\', \'Division of Infectious Diseases, Department of Medicine II, Medical Center - University of Freiburg and Faculty of Medicine, University Hospital Freiburg, Freiburg, Germany.\', \'Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.\', \'Department of Pneumology and Critical Care Medicine, Thoraxklinik, University of Heidelberg, Translational Lung Research Enter Heidelberg, German Center for Lung Research, Heidelberg, Germany.\', \'Department of Biomedical Informatics at the Center for Preventive Medicine and Digital Health (CPD-BW), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.\', \'Institute for Transfusion Medicine and Gene Therapy, University of Freiburg and Faculty of Medicine, University Hospital Freiburg, Freiburg, Germany.\', \'Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.\', \'Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.\', \'Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg and Faculty of Medicine, University Hospital Freiburg, Breisacher Str. 115, 79106, Freiburg, Germany. Klaus.warnatz@uniklinik-freiburg.de.\', \'Center for Chronic Immunodeficiency, Medical Center - University of Freiburg and Faculty of Medicine, University Hospital Freiburg, Freiburg, Germany. Klaus.warnatz@uniklinik-freiburg.de.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s10875-021-01193-2
?:hasPublicationType
?:journal
  • Journal of clinical immunology
is ?:pmid of
?:pmid
?:pmid
  • 34893946
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.611
?:rankingScore_hIndex
  • 84
is ?:relation_isRelatedTo_publication of
?:title
  • Case Series: Convalescent Plasma Therapy for Patients with COVID-19 and Primary Antibody Deficiency.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all